Literature DB >> 2616429

Non-steroidal anti-inflammatory drug ingestion: retrospective study of 272 bleeding or perforated peptic ulcers.

F H Smedley1, M Taube, R Leach, C Wastell.   

Abstract

The ingestion of non-steroidal anti-inflammatory drugs (NSAID) in 272 patients with bleeding or perforated peptic ulcer was compared with 272 age/sex matched controls. A significantly higher proportion of patients with gastric ulcers had received NSAID than those with duodenal ulcers. Twelve of 90 (13%) patients admitted with bleeding duodenal ulcers had received NSAID compared with 11 of 26 (42%) patients with bleeding gastric ulcers (P = 0.003). Sixteen of 132 (12%) patients with perforated duodenal ulcer were taking NSAID compared with 8 of 24 (33%) patients with perforated gastric ulcer. Thirty eight percent of patients with both bleeding and perforated gastric ulcers had received NSAID compared with 13% bleeding and perforated duodenal ulcers (P less than 0.002). This study confirms the association of NSAID and complicated peptic ulcer in patients of over 65 years and highlights the particular susceptibility of the gastric mucosa to their injurious effect.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2616429      PMCID: PMC2429586          DOI: 10.1136/pgmj.65.770.892

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  13 in total

1.  Upper gastrointestinal disease in rheumatoid arthritis.

Authors:  D C Sun; S H Roth; C S Mitchell; D W Englund
Journal:  Am J Dig Dis       Date:  1974-05

2.  Bleeding from peptic ulcers and use of non-steroidal anti-inflammatory drugs in the Romford area.

Authors:  J D O'Brien; W R Burnham
Journal:  Br Med J (Clin Res Ed)       Date:  1985-12-07

3.  Indomethacin and perforated duodenal ulcer.

Authors:  M R Thompson
Journal:  Br Med J       Date:  1980-02-16

4.  Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer.

Authors:  K Somerville; G Faulkner; M Langman
Journal:  Lancet       Date:  1986-03-01       Impact factor: 79.321

5.  Rising frequency of ulcer perforation in elderly people in the United Kingdom.

Authors:  R Walt; B Katschinski; R Logan; J Ashley; M Langman
Journal:  Lancet       Date:  1986-03-01       Impact factor: 79.321

6.  Incidence of gastric lesions in patients with rheumatic disease on chronic aspirin therapy.

Authors:  G R Silvoso; K J Ivey; J H Butt; O O Lockard; S D Holt; C Sisk; W N Baskin; P A Mackercher; J Hewett
Journal:  Ann Intern Med       Date:  1979-10       Impact factor: 25.391

7.  Non-steroidal anti-inflammatory drugs and peptic ulcer perforation.

Authors:  D S Collier; J A Pain
Journal:  Gut       Date:  1985-04       Impact factor: 23.059

8.  What has happened to perforated peptic ulcer?

Authors:  R M Watkins; A R Dennison; J Collin
Journal:  Br J Surg       Date:  1984-10       Impact factor: 6.939

9.  Gastroscopic evaluation of anti-inflammatory agents.

Authors:  I Caruso; G Bianchi Porro
Journal:  Br Med J       Date:  1980-01-12

10.  Aspirin ingestion and perforated peptic ulcer.

Authors:  J M Duggan
Journal:  Gut       Date:  1972-08       Impact factor: 23.059

View more
  4 in total

1.  Surgical management of perforated peptic ulcer disease.

Authors:  K J Sweeney; M O Faolain; D Gannon; T F Gorey; M J Kerin
Journal:  Ir J Med Sci       Date:  2006 Apr-Jun       Impact factor: 1.568

2.  Respiratory distress and chest pain: a perforated peptic ulcer with an unusual presentation.

Authors:  David I Bruner; Corey Gustafson
Journal:  Int J Emerg Med       Date:  2011-06-22

3.  Influence of age, comorbidity, type of operation and other variables on lethality and duration of post-operative hospital stay in patients with peptic ulcer. An analysis of 303 surgically treated patients.

Authors:  J Högel; R J Rieker; R Eisele; E Schmid
Journal:  Langenbecks Arch Chir       Date:  1996

Review 4.  Rheumatoid arthritis in the aged. Incidence and optimal management.

Authors:  G Nesher; T L Moore
Journal:  Drugs Aging       Date:  1993 Nov-Dec       Impact factor: 3.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.